Posted by djmmm on February 4, 2002, at 13:45:15
Links, etc.
http://www.neurocrine.com/html/clin_anxietyDepression.htm
http://www.lilly.com/about/investor/00report/english/pipeline.html
http://www.frx.com/careers/prodmarkets.shtml
Organon has the following in its pipeline:
5ht1a agonist (ariza) phase 3
5ht2c agonist
dopamine + serotonin + norepinephrine reuptake inhibitor
GRF antagonist
abbot labs has a drug in pre-clinical phase for depression/epilepsy/migraneJuvantia Pharma has an alpha2c adrenergic med in pre-clinical phase
Novartis Pharmaceutical Corporation has a Neurokinin 1 antagonist currently in phase 2
pfizer has a 5-HT1A auto receptor agonist in its pipeline
Lexicon Genetics have developed a LG527 enzyme inhibitor for the treatment of depression... they are in pre-clinical phase (mice lacking this gene show increased activity, etc)
Memory Pharmaceuticals has something for major depression in its pipeline
http://www.memorypharm.com/strategy_pipeline.htmlCyberonics Inc will get FDA approval for VNS (Vagus Nerve Stimulation Therapy) for the treatment of Depression, in June of this year..currently they are in phase 3
Lamictal is in phase 3 for depression
...Im sure there are many more.
poster:djmmm
thread:92834
URL: http://www.dr-bob.org/babble/20020131/msgs/92834.html